Atenolol PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering a Atenolol PCD pharma franchise across India. Our portfolio spans 4 Atenolol formulations in Tablet form, backed by consistent quality and monopoly-based distribution rights for our franchise partners.
What is Atenolol?
Atenolol is a cardioselective beta-1 adrenergic blocker that slows the heart rate and reduces the force of contraction, lowering blood pressure and the heart's oxygen demand. Its selectivity for cardiac receptors makes it a long-standing choice for blood-pressure and rhythm control. Its profile is documented on PubChem.
Therapeutic Applications
Atenolol tablets are prescribed for hypertension, chronic stable angina, certain cardiac arrhythmias and post-myocardial-infarction management, often in fixed-dose combinations with amlodipine or chlorthalidone. It is prescribed by cardiologists and general physicians.
Why Atenolol is a High-Potential Molecule for Distributors
As a well-established, low-cost beta-blocker on the WHO Essential Medicines List, atenolol enjoys deep prescriber trust and steady, lifelong repeat demand across a large hypertensive population. Its combination with amlodipine or a diuretic creates value-added SKUs that fit neatly into a cardio-diabetic portfolio. The molecule's simplicity and affordability make it an easy, dependable addition to any cardiac franchise range.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district and state-wise monopoly rights, WHO-GMP certified and DCGI-approved manufacturing, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent supply and billing model helps you build a profitable, protected business in your territory.
References
- PubChem — Atenolol
- MedlinePlus — High Blood Pressure
- PubMed — Atenolol literature
Our formulations of Atenolol find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: